JP2012516347A5 - - Google Patents

Download PDF

Info

Publication number
JP2012516347A5
JP2012516347A5 JP2011548281A JP2011548281A JP2012516347A5 JP 2012516347 A5 JP2012516347 A5 JP 2012516347A5 JP 2011548281 A JP2011548281 A JP 2011548281A JP 2011548281 A JP2011548281 A JP 2011548281A JP 2012516347 A5 JP2012516347 A5 JP 2012516347A5
Authority
JP
Japan
Prior art keywords
compound
phenothiazine
soluble
water
residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011548281A
Other languages
English (en)
Japanese (ja)
Other versions
JP5828587B2 (ja
JP2012516347A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/022342 external-priority patent/WO2010088340A1/en
Publication of JP2012516347A publication Critical patent/JP2012516347A/ja
Publication of JP2012516347A5 publication Critical patent/JP2012516347A5/ja
Application granted granted Critical
Publication of JP5828587B2 publication Critical patent/JP5828587B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011548281A 2009-01-28 2010-01-28 オリゴマー−フェノチアジン結合体 Active JP5828587B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14801609P 2009-01-28 2009-01-28
US61/148,016 2009-01-28
PCT/US2010/022342 WO2010088340A1 (en) 2009-01-28 2010-01-28 Oligomer-phenothiazine conjugates

Publications (3)

Publication Number Publication Date
JP2012516347A JP2012516347A (ja) 2012-07-19
JP2012516347A5 true JP2012516347A5 (https=) 2013-03-14
JP5828587B2 JP5828587B2 (ja) 2015-12-09

Family

ID=42101449

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011548281A Active JP5828587B2 (ja) 2009-01-28 2010-01-28 オリゴマー−フェノチアジン結合体

Country Status (8)

Country Link
US (3) US20120046279A1 (https=)
EP (1) EP2391386B1 (https=)
JP (1) JP5828587B2 (https=)
CN (1) CN102300588B (https=)
AU (1) AU2010208274B2 (https=)
CA (1) CA2749126C (https=)
MX (1) MX2011007940A (https=)
WO (1) WO2010088340A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008331868B2 (en) 2007-11-28 2015-02-12 Nektar Therapeutics Oligomer-tricyclic conjugates
MX2011007940A (es) 2009-01-28 2011-08-15 Nektar Therapeutics Conjugados de oligomero-fenotiazina.
WO2011091050A1 (en) * 2010-01-19 2011-07-28 Nektar Therapeutics Oligomer-tricyclic conjugates
WO2013043744A2 (en) 2011-09-21 2013-03-28 Inception 1, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
US9375486B2 (en) 2012-09-17 2016-06-28 Nektar Therapeutics Oligomer-containing benzamide-based compounds
US9695138B1 (en) * 2016-10-17 2017-07-04 Acenda Pharma, Inc. Phenothiazine derivatives and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2607773A (en) 1952-08-19 Processes for preparing phenthi-
US2519886A (en) 1950-08-22 Beta-bimethylaminoethylphenothia
US2530451A (en) 1950-11-21 Phenothiazines
GB641452A (en) 1946-12-09 1950-08-09 Rhone Poulenc Sa Improvements in or relating to the preparation of derivatives of phenthiazine
US3987042A (en) 1969-03-03 1976-10-19 Claude Gueremy Phenothiazine derivative
FR2632521B1 (fr) 1988-06-10 1990-09-14 Rhone Poulenc Sante Nouveaux derives de la phenothiazine, leur preparation et les compositions pharmaceutiques qui les contiennent
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
WO2002057244A1 (en) 2001-01-19 2002-07-25 Cytokinetics, Inc. Phenothiazine kinesin inhibitors
US6835802B2 (en) 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US7122201B2 (en) 2001-06-28 2006-10-17 Baxter International Inc. Composition and method for reducing adverse interactions between phenothiazine derivatives and plasma using surfactants and amino acids
AR047938A1 (es) * 2003-08-25 2006-03-15 Combinatorx Inc Formulaciones, conjugados y combinaciones de farmacos para el tratamiento de neoplasmas
WO2005058367A2 (en) * 2003-12-16 2005-06-30 Nektar Therapeutics Al, Corporation Pegylated small molecules
US20080112257A1 (en) * 2006-11-10 2008-05-15 Masatoshi Masuda Mixing device for tub
AU2008226791B2 (en) * 2007-03-12 2014-01-16 Nektar Therapeutics Oligomer-antihistamine conjugates
MX2011007940A (es) 2009-01-28 2011-08-15 Nektar Therapeutics Conjugados de oligomero-fenotiazina.

Similar Documents

Publication Publication Date Title
JP2012516347A5 (https=)
JP5181347B2 (ja) ポドフィロトキシン類の高分子結合体
JP5249016B2 (ja) タキサン類の高分子結合体
JP2010527913A5 (https=)
JP2011530597A5 (https=)
JP2012017342A5 (https=)
JP2018518201A5 (https=)
JP2020536847A5 (https=)
JP2013523896A5 (https=)
JP2008542285A5 (https=)
JP2020536845A5 (https=)
JP2012502990A5 (https=)
JP2011528654A5 (https=)
JPWO2008010463A1 (ja) コンブレタスタチン類の高分子結合体
JP2011511075A5 (https=)
JP2012521201A5 (https=)
JP2014515406A5 (https=)
JP2022533069A5 (https=)
JP2013518832A5 (https=)
JP2013525414A5 (https=)
JP2014503548A5 (https=)
JP2008266635A5 (ja) 活性エネルギー線硬化型液体組成物、水性インク及び液体カートリッジ
JP2010505865A5 (https=)
JP2011513377A5 (https=)
AU2017279536A1 (en) Non-cleavable polymer conjugated with αvβ3 integrin thyroid antagonists